RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 121 filers reported holding RA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $71,320,000 | +74.5% | 1,519,718 | -12.1% | 2.28% | +36.6% |
Q3 2019 | $40,868,000 | -20.7% | 1,728,019 | +0.9% | 1.67% | -9.9% |
Q2 2019 | $51,510,000 | +53.1% | 1,713,000 | +14.0% | 1.85% | +43.4% |
Q1 2019 | $33,645,000 | +23.1% | 1,502,000 | 0.0% | 1.29% | +17.9% |
Q4 2018 | $27,336,000 | +294.9% | 1,502,000 | +292.5% | 1.09% | +341.1% |
Q3 2018 | $6,923,000 | +81.8% | 382,700 | 0.0% | 0.25% | +85.1% |
Q2 2018 | $3,808,000 | +87.4% | 382,700 | 0.0% | 0.13% | +91.4% |
Q1 2018 | $2,032,000 | +201.9% | 382,700 | +383.5% | 0.07% | +169.2% |
Q4 2017 | $673,000 | -54.9% | 79,150 | -22.5% | 0.03% | -61.2% |
Q3 2017 | $1,491,000 | -3.7% | 102,150 | +23.7% | 0.07% | -19.3% |
Q2 2017 | $1,548,000 | -59.1% | 82,593 | -53.6% | 0.08% | -43.2% |
Q1 2017 | $3,786,000 | -23.0% | 177,830 | -45.1% | 0.15% | -27.7% |
Q4 2016 | $4,916,000 | – | 323,630 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|